Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Silver Lake In Talks To Buy Workday, Sources Say - Reuters
• PM Super Fund Reveals Marilia Bento, Chair of the Special Committee Refuses Cross Examination, Catherine Stretch Owned Shares in Parent Company of MGLIT, and Sets Record Straight on Matters in Emerita
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c